SUTANTATUG ENVEDOTIN
UNII STG683M7KV

Substance Identification & Data

This profile provides standardized clinical and technical data for Sutantatug Envedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) STG683M7KV.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3049680-25-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
STG683M7KV
CAS Registry Number
3049680-25-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SUTANTATUG ENVEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
INN ID
13839
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sutantatug Envedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SUTANTATUG ENVEDOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN NECTIN 4) (HUMAN-MUS MUSCULUS MONOCLONAL SYS6002 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SYS6002 .KAPPA.-CHAIN, DIMER, 294,294'-DIAMIDE WITH N-(((4-((N-(2-(2-(2-(2-AMINOETHOXY)ETHOXY)ETHOXY)ACETYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS NECTIN4 (NECTIN-4, NECTIN CELL ADHESION MOLECULE 4, PVRL4, POLIOVIRUS RECEPTOR-RELATED 4, PPR4, LNIR)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF TWO GLUTAMINYL RESIDUES TO ENVEDOTIN, COMPRISING A CLEAVABLE LINKER AND MONOMETHYLAURISTATIN E (MMAE) (SUTANTATUG ENVEDOTIN)
SUTANTATUG ENVEDOTIN [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record